Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteasome Inhibitors Decrease the Viability of Pulmonary Arterial Smooth Muscle Cells by Restoring Mitofusin-2 Expression under Hypoxic Conditions
I‐Chen Chen, Yi‐Ching Liu, Yen-Hsien Wu, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 873-873
Open Access | Times Cited: 11

Showing 11 citing articles:

Current Advances of Mitochondrial Dysfunction and Cardiovascular Disease and Promising Therapeutic Strategies
Dexiang Xia, Yue Liu, Peng Wu, et al.
American Journal Of Pathology (2023) Vol. 193, Iss. 10, pp. 1485-1500
Open Access | Times Cited: 14
Cancer Therapy-Associated Pulmonary Hypertension and Right Ventricular Dysfunction: Etiologies and Prognostic Implications
Orly Leiva, William Beaty, Steven Soo, et al.
Reviews in Cardiovascular Medicine (2024) Vol. 25, Iss. 3, pp. 87-87
Open Access | Times Cited: 5
B-cells in pulmonary arterial hypertension: friend, foe or bystander?
S. Sangès, Wen Tian, Sylvain Dubucquoi, et al.
European Respiratory Journal (2024) Vol. 63, Iss. 4, pp. 2301949-2301949
Open Access | Times Cited: 4
Mfn2 regulates calcium homeostasis and suppresses PASMCs proliferation via interaction with IP3R3 to mitigate pulmonary arterial hypertension
R. Wang, Jie Wang, Jing Yu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Evaluation of Proteasome Inhibitors in the Treatment of Idiopathic Pulmonary Fibrosis
I‐Chen Chen, Yi‐Ching Liu, Yen-Hsien Wu, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1543-1543
Open Access | Times Cited: 9
Molecular Cardiotoxic Effects of Proteasome Inhibitors Carfilzomib and Ixazomib and Their Combination with Dexamethasone Involve Mitochondrial Dysregulation
Ayşe Tarbın Jannuzzi, Nalan Sümeyra Korkmaz, Ayşenur Günaydın Akyıldız, et al.
Cardiovascular Toxicology (2023)
Closed Access | Times Cited: 5
Mitochondria in hypoxic pulmonary hypertension, roles and the potential targets
Yumei Geng, Yu Hu, Fang Zhang, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 4
Proteasome inhibitor bortezomib prevents proliferation and migration of pulmonary arterial smooth muscle cells
Yi‐Ching Liu, Yu‐Hsin Tseng, Yu‐Hsin Kuan, et al.
The Kaohsiung Journal of Medical Sciences (2024) Vol. 40, Iss. 6, pp. 542-552
Open Access | Times Cited: 1
An integrative review of nonobvious puzzles of cellular and molecular cardiooncology
Paweł Uruski, Julia Matuszewska, Aleksandra Leśniewska, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 3
Emerging insights into pulmonary hypertension: the potential role of mitochondrial dysfunction and redox homeostasis
Junming Zhang, Huimin Yan, Yan Wang, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access
The extracellular CIRP as a predictive marker for the endothelial dysfunction in chronic obstructive pulmonary disease combined with pulmonary hypertension
Yun Yao, Haibo Jiang, Dalin Xu, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access
Page 1

Scroll to top